To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Definiens Appoints Professor Dr. Ralf Huss as Chief Medical Officer
28-02-2013
Definiens announced the appointment of renowned surgical and anatomical pathologist Dr. Ralf Huss as Chief Medical Officer (CMO). Professor Huss brings significant expertise in pathology and will play a key role in expanding Definiens’ leading position in image and data analysis for Digital ...
AMRI Promotes Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia
27-02-2013
AMRI announced that it has promoted Takeshi Yura, Ph.D., to Vice President of Discovery and Development Services, Asia. Dr. Yura will report directly to Thomas E. D'Ambra, Ph.D., Chairman, President and CEO. Dr. Yura joined AMRI in January 2011 and most recently served as Senior Director of ...
Anders Hamsten to be installed as new president of Karolinska Institutet
28-01-2013
Outgoing president Harriet Wallberg-Henriksson will pass the baton to Anders Hamsten making him the 21st president of Karolinska Institutet. The Swedish government appoints the president of Karolinska Institutet, and Anders Hamsten will lead Sweden’s medical university until 31 December ...
Biocartis strengthens management team with general counsel
18-01-2013
Biocartis announced that Inge Basteleurs has joined the company as General Counsel. Inge will be a member of Biocartis’ Executive Committee and a director of Biocartis NV. Inge Basteleurs brings to Biocartis a 17-year career as a senior international executive within the biotechnology and ...
OBN announces changes to board of directors
17-01-2013
OBN announced changes to the OBN Board of Directors. Dr Steven Lee is reluctantly standing down as Chairman and his place will be taken by David Laskow-Pooley. Congratulating David on his appointment Steven said that “after 6 years as Chairman and with my business interests becoming ...
New board member for Siegfried
16-01-2013
At the Shareholders’ Meeting scheduled for 18 April 2013, the Board of Directors of Siegfried Holding AG will propose the appointment to the Board of Colin Bond, Chief Financial Officer of Evotec AG. Colin Bond, 52, is a citizen of Great Britain and Switzerland. In 2010, he joined ...
Cherwell invests in industrial microbiology expertise
15-01-2013
Cherwell Laboratories announces the appointment of Abdulmajeed Raji (Ph.D Microbiology) as Microbiology Product Specialist. Prior to joining Cherwell Laboratories, Abdul has had many years’ experience working as a Microbiologist in a variety of sectors including; Academia (University of The ...
Hookipa announces formation of Scientific Advisory Board
14-01-2013
Hookipa Biotech AG announced the formation of its Scientific Advisory Board (SAB). The SAB is chaired by Emeritus Prof. Dr. Paul-Henri Lambert (PhD), former Chief of Vaccine Research and Development for the WHO Global Program for Vaccines and Immunizations. The members include scientists ...
AMRI promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing
14-01-2013
AMRI announced that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately. He will continue to report to Steven R. Hagen, Ph.D., Senior Vice President of Pharmaceutical Development and ...
Thomas Monath and Farshad Guirakhoo join Hookipa Biotech as Chief Medical Officer and Chief Scientific Officer
11-01-2013
Hookipa Biotech AG announced the appointment of two new members to its Management team: Thomas P. Monath as Chief Medical Officer and Farshad Guirakhoo as Chief Scientific Officer. Dr. Thomas P. Monath, serving as consulting Chief Medical Officer will play a key role in setting up Hookipa´s ...
Netmeeting
